These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 21491451)

  • 1. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
    Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
    Ther Deliv; 2010 Jul; 1(1):63-73. PubMed ID: 22816120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a novel lipohydrogel nanocarrier: repaglinide as a lipophilic model drug.
    Ebrahimi HA; Javadzadeh Y; Hamidi M; Barzegar Jalali M
    J Pharm Pharmacol; 2016 Apr; 68(4):450-8. PubMed ID: 27114047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method.
    Rawat MK; Jain A; Mishra A; Muthu MS; Singh S
    Curr Drug Deliv; 2010 Jan; 7(1):44-50. PubMed ID: 20044909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
    Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
    Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery.
    Date AA; Vador N; Jagtap A; Nagarsenker MS
    Nanotechnology; 2011 Jul; 22(27):275102. PubMed ID: 21606564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
    Dhana Lekshmi UM; Poovi G; Kishore N; Reddy PN
    Int J Pharm; 2010 Aug; 396(1-2):194-203. PubMed ID: 20600729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles.
    Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R
    Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide.
    Gonçalves LM; Maestrelli F; Di Cesare Mannelli L; Ghelardini C; Almeida AJ; Mura P
    Eur J Pharm Biopharm; 2016 May; 102():41-50. PubMed ID: 26925503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repaglinide-Solid Lipid Nanoparticles in Chitosan Patches for Transdermal Application: Box-Behnken Design, Characterization, and In Vivo Evaluation.
    Ali HSM; Namazi N; Elbadawy HM; El-Sayed AAA; Ahmed SA; Bafail R; Almikhlafi MA; Alahmadi YM
    Int J Nanomedicine; 2024; 19():209-230. PubMed ID: 38223883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus.
    Jain S; Saraf S
    J Diabetes; 2009 Mar; 1(1):29-35. PubMed ID: 20923517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design.
    Sharma JB; Bhatt S; Saini V; Kumar M
    Assay Drug Dev Technol; 2021; 19(4):262-279. PubMed ID: 34000202
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
    Garg A; Singh S
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
    Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
    Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
    Lingling G; Yuan Z; Weigen L
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.